Clomestrone
Clomestrone[edit]

Clomestrone is a synthetic estrogen that belongs to the class of steroidal estrogens. It is a derivative of estrone, one of the naturally occurring estrogens in the human body. Clomestrone has been studied for its potential use in hormone replacement therapy and other medical applications.
Chemical Structure[edit]
Clomestrone is characterized by its unique chemical structure, which is depicted in the image to the right. The structure is based on the estrane skeleton, which is common to many steroidal estrogens. The modifications to the basic estrone structure give clomestrone its distinct properties.
Mechanism of Action[edit]
As an estrogen, clomestrone exerts its effects by binding to estrogen receptors in various tissues. These receptors are part of the nuclear receptor family and, upon activation by clomestrone, they regulate the expression of specific genes involved in the development and maintenance of female secondary sexual characteristics, as well as other physiological processes.
Medical Applications[edit]
Clomestrone has been investigated for its potential use in hormone replacement therapy, particularly in postmenopausal women. It may help alleviate symptoms associated with menopause, such as hot flashes, osteoporosis, and vaginal atrophy. However, its use is not as widespread as other estrogens like estradiol or conjugated estrogens.
Pharmacokinetics[edit]
The pharmacokinetics of clomestrone involve its absorption, distribution, metabolism, and excretion. Like other steroidal estrogens, clomestrone is metabolized primarily in the liver and excreted in the urine. Its bioavailability and half-life can vary depending on the route of administration and individual patient factors.
Side Effects[edit]
The side effects of clomestrone are similar to those of other estrogens and may include nausea, breast tenderness, headache, and an increased risk of thromboembolic events. Long-term use of estrogens has also been associated with an increased risk of certain types of cancer, such as breast cancer and endometrial cancer.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian